Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Review of Therapies for the Treatment of Oral Chronic Graft-Versus-Host Disease

Margaret Harvey Granitto
Jane M. Fall-Dickson
Colleen K. Norton
Colleen Sanders
CJON 2014, 18(1), 76-81 DOI: 10.1188/14.CJON.76-81

Oral chronic graft-versus-host disease is a frequent complication of allogeneic hematopoietic stem cell transplantation, contributing to patient morbidity and mortality. Although an optimal treatment is not available, several systemic and topical or local therapies have shown efficacy in treating the disease. New therapies are being tested through clinical trials. This article examines the efficacy and safety of reported treatment modalities studied from 2006-2012. Nurses will encounter patients with oral chronic graft-versus-host disease suffering from pain, discomfort, and a decreased quality of life. Knowledge of new therapies found to be effective in managing these symptoms is imperative. Nurses play a key role in the assessment and management of this complex oral disease.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or